Clinical Trials Browser

Nasopharyngeal Carcinoma, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06270706 2024-06-12

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Phase 1 Unknown

77 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologic

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasm Metastasis, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05143970 2024-03-20

CHANCES

Phase 1 Unknown

27 enrolled

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT04780217 2024-03-04

Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors

Phase 1/2 Unknown

42 enrolled

GastrointestinalGynecologic

Carcinoma, Hepatocellular, Ovarian Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Clinical Trials

A-TRAIN

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

CHANCES

Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors

Romantic

DORA

From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy

NIECE

VUBAR

VICTORIA

Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies

Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer

Effect of Stress Ball Use on Anxiety Level During Endometrial Biopsy Procedure

Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer

SENGA

TREND

OPTI-DOSE

Predictors of Ovarian Cancer and Endometrial Cancer for Artificial-Intelligence-Based Screening Tools

MITO END-3

Endometrial Cancer Screening in High-risk Populations

AL3818

UPLIFT

AMT-151 in Patients With Selected Advanced Solid Tumours

Early Detection of Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics

PORTEC-3

An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis

Ketohexokinase Isoforms in Endometrial Cancer.

Comparison of Prognosis in Endometrial Cancer Treated With Different Surgical Methods: Laparoscopy, Robotic-assisted Laparoscopy and Laparotomy

ctDNA-endo

Sentimetre

Study and Transformation of Tumor Molecular Features Screening Model of Endometrial Carcinoma Surgical Approach

ICEMELT

OPTIMUS

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer

Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer

MARF-E

Developing a MRI-based Deep Learning Model to Predict MMR Status

Unusual Infiltrative Patterns of Malignant Cells in Endometrial Carcinoma and Immunohistochemical Expression of P53

Evaluation of MCM5 in Postmenopausal Bleeding Patients

Staging Endometrial caNcer Based on molEcular ClAssification

Patient-Reported Outcomes Among Women Wtih Gynecological Cancer (The CONNECT Study)

Patient Blood Mangement (PBM) Using IV Iron in Patients With Gynecologic Cancer

the Value of Immunohistochemical Expression of Moesin in Endometrial Hyperplasia and Endometrial Carcinoma

RESTORE

Endometrial Lesions Predictions

Detection of Tumor DNA Through Cervical Smear and Liquid Biopsy in Endometrial Cancer Patients and Evaluation of Prognostic and Predictive Values of Tumor DNA Assay

Risk Assessment of Endometrial Hyperplasia and Endometrial Cancer

MIRCE

Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors

Radiomics Based Multimodal Transvaginal Ultrasound Imaging in Endometrial Cancer